US OptionsDetailed Quotes
TGTX250502C42000
- 1.70
- -2.60-60.47%
15min DelayClose May 2 15:59 ET
3.70High1.32Low
3.60Open4.30Pre Close43 Volume178 Open Interest42.00Strike Price10.08KTurnover968.16%IV0.60%PremiumMay 2, 2025Expiry Date1.44Intrinsic Value100Multiplier0DDays to Expiry0.26Extrinsic Value100Contract SizeAmericanOptions Type0.9169Delta0.1303Gamma29.45Leverage Ratio-31.0167Theta0.0000Rho27.00Eff Leverage0.0002Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet